期刊文献+

HPLC同时测定虎贞痛风胶囊中大车前苷、虎杖苷、特女贞苷、白藜芦醇的含量 被引量:5

Simultaneous Determination of Plantamajoside,Polydatin,Specnuezhenide and Resveratrol in Huzhentongfeng Capsule with HPLC
原文传递
导出
摘要 目的:建立同时测定虎贞痛风胶囊中大车前苷、虎杖苷、特女贞苷、白藜芦醇含量的HPLC方法。方法:采用高效液相法测定,色谱条件为Agilent SB-C18色谱柱(4.6 mm×250 mm,5μm),流动相乙腈-0.1%甲酸溶液梯度洗脱,检测波长280 nm,流速1.0 m L·min-1,柱温30℃。结果:大车前苷、虎杖苷、特女贞苷、白藜芦醇分别在0.099 6-1.992(r=0.999 9),0.123-2.46(r=0.999 9),0.145-2.90(r=0.999 9),0.025-0.50μg(r=0.999 8)与峰面积呈良好的线性关系,平均回收率分别为99.27%,99.43%,98.83%,98.07%。结论:该方法快速简便,重复性好,专属性强,可作为虎贞痛风胶囊的质量控制方法。 Objective: The aim of this study was to establish a HPLC method for simultaneous determination of the contents of plantamajoside,polydatin,specnuezhenide and resveratrol in Huzhentongfeng capsules. Method: HPLC was used to determine the contents. The analytical column was Agilent SB-C18column( 4. 6 mm × 250 mm,5 μm). The liquid phase was composed of acetonitrile and 0. 1% formic acid with gradient elution. The detection wavelength was set at 280 nm,the flow rate was 1. 0 m L·min- 1and the column temperature was maintained at 30 ℃. Result: The mass of plantamajoside,polydatin,specnuezhenide and resveratrol with peak areas were within the concentration ranges of 0. 099 6-1. 992 μg( r = 0. 999 9),0. 123-2. 46 μg( r = 0. 999 9),0. 145-2. 90 μg( r = 0. 999 9),0. 025-0. 50 μg( r = 0. 999 8),and the average recoveries were 99. 27%,99. 43%,98. 83%,98. 07%,respectively. Conclusion: The method is rapid and simple,highly reproducible and specific so that it could be used as one of the quality control methods of Huzhentongfeng capsules.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第22期49-52,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家"重大新药创制"科技重大专项(2011ZX09401-307) 广东省科技厅项目(2012A080204003) 广州市生物产业科技重大专项(201300000060) 广东高校产学研结合示范基地项目(cgzhzd0905)
关键词 虎贞痛风胶囊 大车前苷 虎杖苷 特女贞苷 白藜芦醇 Huzhentongfeng capsule plantamajoside polydatin specnuezhenide resveratrol
  • 相关文献

参考文献4

二级参考文献75

共引文献58

同被引文献73

  • 1苏筠霞,刘明龙,刘天喜,肖祖容,李建华.痛风定对尿酸性肾病大鼠肾脏肿瘤坏死因子-α、单核细胞趋化蛋白-1和细胞间黏附分子-1mRNA的影响[J].兰州大学学报(医学版),2013,39(1):6-10. 被引量:7
  • 2关宝生,白雪,王艳秋,尹相林,李若男,周宪君,徐辉,杜文彦,邱洪斌.痛风/高尿酸血症患者生活习惯的危险因素[J].中国老年学杂志,2014,34(2):455-457. 被引量:62
  • 3王海燕.肾脏病学.3版.北京:人民卫生出版社,2008.
  • 4中国药典.2015.一部:69,246,327.
  • 5Lin SP1,Chu PM,Tsai SY, et al.Pharmacokinetics and tissue distribution of resveratrol emodin and their metabolites after intake of Polygonum cuspidaturn in rats / J) .J Ethnophar macol,2012,144(3):671-676.
  • 6Punzi L,So A.Serum uric acid and gout:from the past to molecular biology (J/ .Current Medical Research and Opinion,2013,29(3):3-8.
  • 7Wang J,Liu S,Ma B,et al.Rapid screening and detection of XOD inhibitors from S.tamariscina by ultrafiltration LC- PDA-ESI-MS combined with HPCCC [J] .Anal Bioanal Chem,2014,406(28):7379-7387.
  • 8Faruque L1,Ehteshami-Afshar A,Wiebe N,et al.A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout [J] .Semin Arthritis Rheum,2013,43(3):367-375.
  • 9FirestehaGS,BuddRC,GabrielsE,等.凯利风湿病学[M].9版.栗占国译.北京:北京大学医学出版社~015:1673.1674.
  • 10Esparza MN,Garcia NV.Hypouricernia and tubular transportofuric acid /J/ .Nefrologia,2011,31(1):44-50.

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部